Vasomotor symptoms resulting from natural menopause: a systematic review and network meta‐analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause

@article{Sarri2017VasomotorSR,
  title={Vasomotor symptoms resulting from natural menopause: a systematic review and network meta‐analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause},
  author={Grammati Sarri and Hugo Pedder and Sofia Dias and Y Guo and Mary Ann Lumsden},
  journal={BJOG: An International Journal of Obstetrics \& Gynaecology},
  year={2017},
  volume={124},
  pages={1514 - 1523}
}
Vasomotor symptoms (VMSs) are the hallmarks of menopause, occurring in approximately 75% of postmenopausal women in the UK, and are severe in 25%. 
28 Citations
Menopause.
TLDR
The menopausal transition is a time when many physical and psychological changes are occurring for women, and it is important to understand what is within normal physiologic changes and what may represent pathologic changes.
The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women
Hormone replacement therapy (HRT) is the most commonly used treatment for managing menopausal symptoms and has been shown to be the most effective intervention in this context. The decision whether
British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer
This guidance document by the British Menopause Society provides an overview of the management of women experiencing estrogen deficiency symptoms and arthralgia following a breast cancer diagnosis.
Managing menopausal vasomotor symptoms in older women.
TLDR
This review considers the persistent vasomotor symptoms of menopause-hot flashes-from the perspective of older women, and recommends strategic management of VMS in older women with the goal of promoting health and maintaining quality of life.
The Women's Study for the Alleviation of Vasomotor Symptoms (WAVS): a randomized, controlled trial of a plant-based diet and whole soybeans for postmenopausal women
TLDR
The combination of a low-fat, vegan diet and whole soybeans was associated with reduced frequency and severity of hot flashes and improved quality of life in vasomotor, psychosocial, physical, and sexual domains in postmenopausal women.
Impact of microbiota on the use and effects of isoflavones in the relief of climacteric symptoms in menopausal women – A review
TLDR
Phytoestrogens, especially isoflavones, have many benefits in the climacteric phase, due to the similarity of their chemical structure with the hormone estradiol (E2), reducing the rate of menopause side effects and resulting in symptom relief.
Modern approaches to the management of menopause
TLDR
An analytical review of modern publications highlighting modern approaches to improving the quality and increasing life expectancy in postmenopausal women finding MHT the most effective treatment for symptom relief is carried out.
Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms.
  • L. Newson, A. Lass
  • Medicine
    The British journal of general practice : the journal of the Royal College of General Practitioners
  • 2018
TLDR
The role of hormone replacement therapy (HRT) in the management of menopausal symptoms is discussed, and the advantages of different types and preparations of HRT are considered, based on the current medical evidence.
Progesterone for treatment of symptomatic menopausal women
  • J. Prior
  • Medicine
    Climacteric : the journal of the International Menopause Society
  • 2018
TLDR
Evidence is highlighted that oral micronized progesterone (progesterone) is effective for hot flushes and night sweats, improves sleep and is likely safe in menopausal women (who are more than 1 year since last menstruation).
Antioxidant capacity and menopausal symptoms
TLDR
Evidence from observational studies has shown that adherence to diets with increased antioxidant content was related to fewer vasomotor symptoms and better psychological well-being in menopausal women.
...
1
2
3
...

References

SHOWING 1-10 OF 96 REFERENCES
Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms
  • A. Ferrari
  • Medicine
    The journal of obstetrics and gynaecology research
  • 2009
Aim:  The aim of the present study was to assess the efficacy and safety of a standardized compound based on an extract of soy phytoestrogens, with high doses of isoflavones in the management of
The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study.
TLDR
The current study provides the first evidence that a single daily dose of 30 mg of synthetic genistein reduces hot flush frequency and duration.
Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
TLDR
Among healthy women, the use of escitalopram (10-20 mg/d) compared with placebo resulted in fewer and less severe menopausal hot flashes at 8 weeks of follow-up.
Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation
TLDR
Powdered energy drinks are not commonly consumed in Australia and were poorly tolerated in this study, suggesting that other methods of isoflavone delivery may be more appropriate in this culture, in future trials.
Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation
TLDR
There was a high compliance rate among individual patients, and there was a 25% withdrawal rate from the study in the active group, but the incidence of complaints of bad taste tended to be higher in theactive group, and the total number of adverse events was significantly higher in this group.
Tibolone and low‐dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability
TLDR
This study compared the vaginal bleeding pattern during administration of tibolone and low‐dose continuous combined estradiol plus norethisterone acetate (E2/NETA) to test efficacy on vasomotor symptoms and vaginal atrophy.
Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial
TLDR
BZA 20 mg paired with CE 0.45 or 0.625 mg is effective, with short-term safety, for treating vasomotor symptoms in postmenopausal women.
Duration of menopausal vasomotor symptoms over the menopause transition.
TLDR
Frequent VMS lasted more than 7 years during the menopausal transition for more than half of the women and persisted for 4.5 years after the FMP, and they may last longer for African American women.
Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study
TLDR
It is suggested that soy protein containing 42 or 58 mg of isoflavones is no more effective than is oflavone-extracted soy protein for improving the number and severity of vasomotor symptoms in peri- and postmenopausal women.
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
TLDR
Paroxetine CR may be an effective and acceptable alternative to hormone replacement and other therapies in treating menopausal hot flash symptoms.
...
1
2
3
4
5
...